Refractory pityriasis rubra pilaris treated with abrocitinib
Pityriasis rubra pilaris is a rare idiopathic papulosquamous disorder that significantly impacts the quality of life and is often refractory to conventional therapies. This study presents a case of successful treatment with an abrocitinib JAK1 inhibitor after several conventional and biologic thera...
Saved in:
Main Author: | Filip Rob |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2025-01-01
|
Series: | Dermatology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/dr/article/view/10105 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
by: Grace Xiong, BHSc, et al.
Published: (2025-04-01) -
Case report: Generalized granuloma annulare successfully treated with baricitinib in two cases
by: Marina Yunoki, et al.
Published: (2025-01-01) -
False Mating of Blackbirds (Turdus merula) and Fieldfares (Turdus pilaris)
by: Dariusz Wysocki, et al.
Published: (2025-01-01) -
A case of pityriasis rubra pilaris secondary to ponatinib
by: Ariana Nateghi, et al.
Published: (2025-01-01) -
Purpuric pityriasis rosea in patients with anorexia nervosa
by: Giulia Ciccarese, et al.
Published: (2025-01-01)